logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Acute Leukemia

    Medications for Acute Leukemia

    FiltersReset Filters
    8 results

    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Fresenius Kabi USA, LLC
      Usage: This drug is indicated for various conditions requiring intravenous or intramuscular administration, including endocrine disorders, rheumatic diseases, dermatologic issues, severe allergic reactions, and certain gastrointestinal and respiratory diseases. It also addresses hematologic, neoplastic, and neurologic disorders, as well as promoting healing in soft tissue and joint conditions.

    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Hikma Pharmaceuticals USA Inc.
      Usage: This drug is indicated for intravenous or intramuscular use in various conditions, including endocrine disorders (e.g., adrenal insufficiency), rheumatic disorders (e.g., rheumatoid arthritis), allergic states, skin diseases, and gastrointestinal issues. It also addresses respiratory, hematologic, neoplastic, and nervous system disorders, with specific applications for intra-articular, soft tissue, and intralesional administration.

    • methylprednisolone

      (methylprednisolone)
      Greenstone LLC
      Usage: Methylprednisolone is indicated for various conditions including adrenocortical insufficiency, rheumatic disorders, collagen diseases, severe dermatologic and allergic conditions, ophthalmic inflammatory diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, acute multiple sclerosis exacerbations, and certain cases of tuberculous meningitis.

    • prednisolone sodium phosphate

      (Prednisolone Sodium Phosphate)
      Edenbridge Pharmaceuticals LLC.
      Usage: Prednisolone Sodium Phosphate Oral Solution is indicated for various conditions including severe allergic reactions, dermatologic diseases, edematous states, endocrine disorders, gastrointestinal diseases, hematologic disorders, neoplastic diseases, acute exacerbations of multiple sclerosis, ophthalmic diseases, respiratory diseases, rheumatic disorders, and specific tuberculosis complications.

    • prednisolone sodium phosphate oral solution

      (Prednisolone Sodium Phosphate)
      BioComp Pharma, Inc.
      Usage: Prednisolone sodium phosphate oral solution is indicated for severe allergic reactions, dermatologic diseases, edematous states, endocrine disorders, gastrointestinal diseases, hematologic disorders, neoplastic diseases, multiple sclerosis exacerbations, ocular inflammatory conditions, respiratory diseases, rheumatic disorders, and certain miscellaneous conditions such as tuberculous meningitis and organ rejection.

    • rayos

      (prednisone)
      Horizon Therapeutics USA, Inc.
      Usage: RAYOS is indicated for severe allergic conditions, various dermatologic and endocrine diseases, gastrointestinal disorders (like Crohn's and ulcerative colitis), hematologic issues, neoplasms, nervous system conditions (such as multiple sclerosis), certain ophthalmic diseases, organ transplant rejection, pulmonary disorders, renal conditions, rheumatologic ailments, and specific infectious diseases.

    • revuforj

      (revumenib)
      Syndax Pharmaceuticals, Inc.
      Usage: REVUFORJ is indicated for treating relapsed or refractory acute leukemia with a KMT2A gene translocation in adults and pediatric patients aged 1 year and older.

    • vincristine sulfate

      (VINCRISTINE SULFATE)
      Hospira, Inc.
      Usage: Vincristine Sulfate Injection is indicated for acute leukemia and is also effective in combination with other agents for Hodgkin's disease, non-Hodgkin's lymphomas, rhabdomyosarcoma, neuroblastoma, and Wilms' tumor.